Farmacef

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Farmacef

Quick Facts

Property Description
Active Ingredient Cefalexin (Cephalexin)
Form Oral Capsule, Tablet, or Suspension
Pharmacological Class First-Generation Cephalosporin Antibiotic
Common Use Principle Kills susceptible bacteria (bactericidal action)
Origin Semi-Synthetic

What Kind of Medicine is Farmacef? (Type, Class, and Composition)

Farmacef is a widely available oral antibiotic containing the active ingredient Cefalexin (or Cephalexin). It is classified as a first-generation cephalosporin antibiotic, which is part of the larger beta-lactam class of antimicrobials. The compound is semi-synthetic, meaning its structure is derived from natural origins but modified chemically to enhance its stability and effectiveness upon oral administration. The broad-spectrum effectiveness of Cefalexin against common bacteria is clinically recognized and is widely supported by pharmacological studies.

What is the General Goal of Taking Farmacef? (Purpose and Benefit)

As a bactericidal agent, the core therapeutic goal of Farmacef is to bring about the rapid killing of susceptible bacteria that cause infection, which is achieved by disrupting their protective cell wall synthesis. This focused action is why Cefalexin is a frequently prescribed, prescription-only medication. The drug is often selected for infections, such as those involving the skin or urinary tract, where a reliable and definitive action against common bacterial culprits is needed.

How is Farmacef Usually Available? (Form and Patient Group)

A distinctive feature of this medication is its flexibility in delivery. Farmacef is commonly supplied as an oral capsule or tablet but is also widely available as a liquid suspension (syrup). This oral liquid form makes the drug highly suitable for pediatric patients (children) or adults who cannot easily swallow pills, ensuring that a consistent and appropriate dose can be taken to complete the full course of therapy.

Regulatory References

  1. Cephalosporins - StatPearls - NCBI Bookshelf
  2. Cephalexin - StatPearls - NCBI Bookshelf
  3. Cephalexin Capsules Label (FDA DailyMed)

What side effects are possible with Farmacef?

Possible Side Effects and Safety Information

Official Adverse Reaction Profile

The safety profile for Farmacef (Cefalexin) is formally documented in regulatory prescribing information, classifying reactions primarily by incidence and affected physiological system. The most common adverse reactions reported in official sources involve the Gastrointestinal System, including diarrhea, nausea, vomiting, and abdominal pain. Reactions such as rash, pruritus (itching), and urticaria are classified as uncommon.

System-Organ Classes and Serious Reactions

The drug's safety documentation includes effects across multiple System-Organ Classes, such as the Blood, Liver, Kidney, and Nervous System. Rare but serious adverse reactions are formally listed and include severe hypersensitivity events, such as anaphylaxis and severe skin conditions like Stevens-Johnson Syndrome (SJS). The possibility of Clostridium difficile-associated diarrhea (CDAD), which can occur during or up to two months after treatment, is a critical, label-documented safety feature associated with its use.

Safety Constraints and Special Considerations

Farmacef is contraindicated in individuals with a history of known allergy or hypersensitivity to the cephalosporin class of antibiotics. Regulatory notes specify that caution is advised for patients with a known history of penicillin allergy due to the potential for cross-sensitivity. Special consideration is formally documented for patients with impaired renal function, as the risk of certain central nervous system effects, such as seizures, is increased in this population if clearance is compromised. Furthermore, prolonged use may lead to the overgrowth of non-susceptible organisms. The medicine is known to interfere with certain laboratory tests, potentially causing a false-positive result for urine glucose and a positive Direct Coombs' test.

Overdose and Emergency Response

Overdose and When to Seek Help

Farmacef (Cefuroxime) is an antibiotic, and taking a significantly higher dose than prescribed can lead to severe adverse effects. Overdose information from authoritative sources focuses on the potential for central nervous system (CNS) toxicity.

Overdose Symptoms and Risk Factors

Symptoms of a significant overdose may include cerebral irritation, which can lead to convulsions (seizures).

The risk of developing neurological symptoms is greater for individuals with pre-existing impaired renal function (kidney disease). Because the drug is primarily eliminated by the kidneys, slower removal of the medicine from the body in these patients can increase serum concentration and the potential for toxicity.

Required Emergency Actions

Seek emergency medical help immediately if you suspect an overdose or if the patient experiences convulsions, collapses, or has severe trouble breathing. Call the poison control center for guidance in any suspected case of over-ingestion.

In the event of an overdose, medical treatment may involve the administration of anticonvulsant agents to manage seizures. To reduce the concentration of the drug in the body, procedures such as haemodialysis or peritoneal dialysis can be used to facilitate the removal of Farmacef from the bloodstream. Always inform emergency personnel of all substances taken.

Therapeutic Uses of Farmacef

What Farmacef Treats: Main Uses and Benefits

Farmacef is commonly used for managing conditions involving bacterial infections across several key areas of the body, offering supportive relief. This medicine is a relevant option for conditions that present with systemic or localized discomfort.

The medication is commonly used in conditions such as cellulitis, uncomplicated cystitis, pharyngitis, tonsillitis, and otitis media. It is applied when groups of symptoms—such as painful urination, pronounced skin swelling, fever, or sore throat—become difficult to tolerate or create noticeable physiological strain.

Symptomatic Relief and Patient Support

Farmacef is relevant for managing symptoms that interfere with daily comfort. The medication helps address symptom clusters that may become intense or disruptive, contributing to a more manageable experience during these symptomatic episodes. The overall therapeutic goal is to support general well-being during symptomatic phases, which contributes to improved day-to-day comfort during periods of acute inflammation and systemic stress.


Quick Fact: Relief for Acute Discomfort

Feature Description
Primary Symptom Focus Symptoms related to inflammatory or irritative states
Key Patient Benefit Supports general well-being during symptomatic phases
When Symptoms are Used Applied in settings marked by temporary physiological imbalance
Conditions Characterized By Conditions characterized by periods of heightened symptoms

Regulatory References

  1. NIH MedlinePlus overview on Cephalexin

Eligibility and Restrictions for Use

Who Can and Cannot Use Farmacef? (Cefazolin Sodium)

This section summarizes the official eligibility and non-eligibility information for Cefazolin Sodium as defined in regulatory documentation.


Populations That Must Not Use Farmacef (Contraindications)

Cefazolin is formally contraindicated and must not be used by patients who have a known history of an immediate, severe allergic reaction (hypersensitivity) to:

  • Cefazolin itself or any other drug within the cephalosporin class of antibiotics.
  • Penicillins or any other beta-lactam antibacterial drugs, due to the risk of cross-hypersensitivity.
  • Dextrose-containing products (only for specific formulations containing dextrose).

Populations Requiring Special Consideration

Population Group Eligibility Status & Rule
Renal Impairment Use requires dosage adjustment. Patients with reduced kidney function must receive a lower daily dosage to prevent accumulation and potential toxicity.
Neonates (Under 1 Month) Use is not recommended. The safety and efficacy of Cefazolin in infants less than one month of age have not been established or are discouraged due to toxicity reports.
Pediatric Patients Generally permitted ge 1 month of age. Use is established for treatment in patients aged one month and older, and for surgical prophylaxis in patients aged 10 to 17 years.
Gastrointestinal History Use with caution. Individuals with a history of serious gastrointestinal disease, particularly colitis, should use this medicine with caution.

What should I know about interactions with other medicines?

Farmacef Interactions with Other Medicines and Products

This section outlines the formally documented interactions for Farmacef (Cefalexin), strictly based on official government regulatory prescribing information.


Interactions Affecting Drug Clearance and Exposure

Interactions primarily involve renal (kidney) clearance, which can alter the concentration of both Farmacef and co-administered medicines.

Interacting Product Regulatory Description
Probenecid Inhibits the renal excretion of Farmacef, resulting in increased and sustained plasma concentrations of Cefalexin.
Metformin Co-administration causes an increase in Metformin plasma concentrations (Cmax and AUC) by decreasing its renal clearance.

Pharmacodynamic and Combined Risk Interactions

Regulatory documents identify additive risk or potentiated effects with certain combinations:

  • Oral Anticoagulants (e.g., Warfarin): May be associated with a prolonged prothrombin time (a measure of blood clotting). Patients with renal or hepatic impairment have an elevated risk.
  • Potent Diuretics (e.g., Furosemide): Concurrent use may increase the risk of nephrotoxicity (kidney-related injury).

Other Documented Interactions and Constraints

Interacting Product Constraint or Requirement
Zinc Supplements May reduce Farmacef absorption. Administration is often advised to be separated by at least 3 hours.
Urine Glucose Tests Farmacef can cause a false-positive reaction in urine glucose tests that use copper reduction methods (e.g., Clinitest®).

Mechanism of Action

The action of Farmacef (Cefalexin) is bactericidal, resulting in the direct cellular destruction of susceptible bacteria. Its mechanism relies on two interconnected domains: inhibiting an essential construction enzyme and triggering the subsequent cellular collapse.

Farmacef works as an irreversible inhibitor of bacterial enzymes called Penicillin-Binding Proteins (PBPs), specifically the transpeptidases. By covalently binding to the enzyme's active site, the drug prevents the final, critical step—the cross-linking of peptidoglycan strands—required to build the rigid protective layer of the bacterial cell wall.

The failure to construct a structurally intact cell wall leaves the bacterial cell vulnerable to high internal fluid pressure. This failure of structural integrity rapidly causes the cell membrane to rupture, a process known as lysis, which is the physiological consequence leading to bacterial cell death.

The mechanism is constrained by bacterial resistance. It is nullified when bacteria produce beta-lactamase enzymes, which hydrolyze and destroy the drug molecule before it can reach the PBPs, or when they develop altered PBPs with reduced binding affinity for the beta-lactam structure.

Dosage and Administration Information

Farmacef (Cefalexin) is administered strictly by the oral route using official dosage forms: capsules, tablets, or a powder requiring reconstitution for liquid suspension.


Administration and Dosing Principles

Instruction Detail
Route of Administration Oral only, via capsule, tablet, or liquid suspension.
Standard Adult Regimen 250 mg every 6 hours or 500 mg every 12 hours. The maximum labeled daily dose is 4 grams for severe infections.
Timing in Relation to Meals May be taken without regard to meals (with or without food).
Preparation Requirements Powder for oral suspension must be reconstituted with water at the time of dispensing and shaken well before each measured dose.

Use Duration and Adjustments

The total duration of administration typically ranges from 7 to 14 days. For infections caused by beta-hemolytic streptococci, official guidelines require the course to be completed for a minimum of 10 days.

Specific dose adjustments are required for certain populations. Pediatric dosing for children over one year is determined by a weight-based calculation (mg/kg of body weight), and must be divided into equal daily doses. For adults experiencing moderate renal impairment (CrCl 30 to 59 mL/min), the maximum dose is restricted and should not exceed 1 gram daily. This structured approach defines the mandatory schedule and constraints for its use.

Recent Clinical Evidence

Farmacef (Cefalexin) was studied in research contexts involving common bacterial infections. The regulatory context of this medicine is based on evidence derived primarily from randomized controlled trials (RCTs) and observational studies that monitor patient outcomes related to physical discomfort and recovery during treatment.

For Uncomplicated Skin and Soft Tissue Infections (SSTIs), short-term RCTs compared Cefalexin against other antibiotic agents and placebo, monitoring the clinical cure rate and treatment failure rate. For skin abscesses, findings were mixed when Cefalexin was compared to placebo after incision and drainage (I&D).

In Uncomplicated Urinary Tract Infections (UTIs), retrospective cohort studies and comparative trials examined its performance. Outcomes research monitored clinical and bacteriological cure. Pharmacokinetic studies describe patterns related to how Cefalexin achieves high concentrations in the urine, a physiological finding relevant to UTIs. Pediatric Patients were also studied for conditions like Otitis Media, contributing to understanding symptom patterns and the use of the liquid suspension form.

Regarding Ear, Nose, and Throat (ENT) Infections, RCTs explored Cefalexin’s use against penicillin and other established agents, tracking bacteriological eradication for conditions like Streptococcal pharyngitis.

What remains uncertain is that follow-up durations were limited in most trials, and there is limited information for long-term outcomes. Because antimicrobial resistance patterns change regionally, comparative evidence is lacking in some recent studies. Furthermore, for some indications, the evidence quality varies across studies, meaning the certainty remains low in drawing broad conclusions about its performance.

Key Studies & References

  1. Cephalexin (Systemic): Drug Information

Frequently Asked Questions (FAQ)

Common questions about Farmacef (FAQ)


Q: Can Farmacef cause stomach problems or nausea?

Yes, regulatory documents indicate that nausea, vomiting, and diarrhea are among the most common adverse reactions reported by patients taking this medication. These effects primarily involve the gastrointestinal system.

Q: How long does Farmacef stay in your system after the last dose?

Official pharmacokinetic information indicates that the concentration of Farmacef in the blood typically peaks about one hour after an oral dose. While its primary effects last several hours, the official product label states that the medicine is generally eliminated from the body within about 6 hours for most individuals.

Q: Can Farmacef affect how my birth control pills work?

Yes, official drug information and patient counseling guides state that cephalexin, the active ingredient in Farmacef, may decrease the effectiveness of hormonal contraceptives. This includes birth control pills, patches, rings, and injections. If you have concerns, it is appropriate to consult a healthcare provider regarding the need for additional contraceptive methods.

Q: What happens if I miss a dose of Farmacef?

Official patient instructions explain the general principle for a missed dose: if it is close to the time for the next scheduled dose, you may be instructed to skip the missed dose and resume your regular schedule. Always consult the specific instructions given by your prescriber or pharmacist regarding how to handle a missed dose.

Q: Can children take Farmacef, and if so, at what age?

Yes, the use of Farmacef is established in pediatric patients, specifically those over one year of age. The safety and effectiveness in children less than one year old is not as well established, and use in infants under one month is generally not recommended.

Q: Can Farmacef be taken with dairy products?

According to official dosing principles, Farmacef may be taken without regard to meals. This includes most foods like dairy products, as the medication is generally designed to be acid-stable. However, a healthcare professional can confirm specific dietary instructions.

Q: What is the maximum amount of time Farmacef should be taken?

The typical course of treatment is administered for 7 to 14 days, though the total duration can vary based on the specific type of infection. The exact length of time for treatment is determined by a healthcare provider based on the type and severity of the infection.

Q: Does Farmacef have an impact on gut health?

Yes, one serious safety feature associated with antibiotics like Farmacef is the potential risk of Clostridium difficile-associated diarrhea (CDAD). This condition can occur during treatment or up to two months afterward and involves an imbalance in the natural bacteria within the gut.

Q: Why does Farmacef need to be stored at a certain temperature?

The liquid suspension form of Farmacef must be kept in a refrigerator (between 2°C and 8°C) to maintain its chemical stability and ensure its potency. Any unused portion of the refrigerated suspension must be discarded after 14 days.

Q: Can Farmacef be used by women who are breastfeeding?

Official information indicates that trace amounts of the medication do pass into breast milk. Studies generally suggest that the drug poses minimal risk to the nursing infant, but discussions with a healthcare provider are always recommended.

Q: Is Farmacef safe for older adults to use?

Geriatric use guidelines note that older adults may be more likely to have reduced kidney function. Because the medicine is cleared by the kidneys, the official label highlights the need for careful monitoring and potential dosage adjustments in this population to prevent the medicine from accumulating.

Q: What are the signs that Farmacef is actually working?

Patient counseling information states that the medicine is working if the symptoms of the infection begin to get better. If symptoms do not improve after a few days of use, or if they worsen, you should follow up with a healthcare provider.

Q: Are there any known issues with Farmacef for people with liver disease?

Official drug information suggests that the medication should be used with caution in individuals with known liver disease. This is because slower removal from the body could potentially increase the effects of the medicine.

Q: Does Farmacef treat viral infections or only bacterial ones?

Farmacef is an antibiotic that works only against susceptible bacterial infections by killing the bacteria. Official usage guidelines state that it is not effective and should not be used to treat infections caused by viruses, such as the common cold or flu.

Q: Is it common to feel tired while taking Farmacef?

Official reports of adverse effects indicate that tiredness and general weakness have been reported by patients using Farmacef. Drowsiness or dizziness is also listed as a possible side effect of the medication.

Q: Is Farmacef the same as cephalexin?

Yes, Farmacef is a brand name. The active ingredient in this medication is the generic medicine known as cephalexin (or Cefalexin), which is recognized by regulatory agencies.

Q: Why is Farmacef sometimes prescribed for skin infections?

Farmacef is formally indicated for the treatment of skin and skin structure infections. This is because it is effective against common bacterial culprits, such as Staphylococcus aureus and Streptococcus pyogenes, that often cause these types of infections.

Q: Can taking Farmacef change the color of your urine?

While not commonly reported, some adverse reaction data includes rare instances of dark or clay-colored stools. These changes are related to elimination, and any concerns about them should be discussed with a healthcare provider.

Q: What is the risk of having an allergic reaction to Farmacef?

Farmacef is formally contraindicated in individuals with a known history of severe allergy to cephalosporins or penicillins. Although the precise numerical risk is not provided, serious hypersensitivity reactions, including anaphylaxis, are listed as a potential risk.

Q: Are there certain supplements that interact badly with Farmacef?

Official drug interaction information notes that products containing the supplement zinc may interfere with the body's absorption of Farmacef and reduce its effectiveness. It is often recommended to separate the administration of the two products by at least three hours.

Q: Is it normal to get a yeast infection after taking Farmacef?

Yeast infections (such as oral or vaginal thrush) are among the known side effects reported with Farmacef use. This is due to the nature of antibiotics, which can lead to the overgrowth of non-susceptible organisms in the body.

Q: What types of bacteria is Farmacef most effective against?

Official microbiology information indicates that Farmacef is primarily effective against susceptible strains of Gram-positive bacteria, such as Staphylococcus aureus and Streptococcus pyogenes. It is also used against specific Gram-negative organisms like E. coli for conditions such as urinary tract infections.

Q: Is there a generic version of Farmacef available?

Yes, the generic medicine containing the active ingredient, cephalexin, is widely available. Regulatory documents list the drug under its generic name, Cephalexin, USP.

Q: Can Farmacef cause dizziness or trouble sleeping?

Official safety data confirms that dizziness has been reported as an adverse effect. Less commonly, effects such as trouble sleeping or restlessness have also been noted by patients.

Q: What should I do if the side effects from Farmacef bother me?

If you experience side effects that are troubling or concerning, consulting your healthcare provider is appropriate. They are best equipped to address individual concerns related to side effects.

Q: Why do people say you shouldn't drink alcohol while taking Farmacef?

While official product labeling does not list a direct chemical interaction with alcohol, healthcare providers often advise against drinking. Alcohol consumption can potentially worsen common side effects like nausea and dizziness, and it can interfere with the body's general ability to fight infection.

Q: Can Farmacef be used long-term for chronic issues?

Farmacef is typically used for a short course of treatment for acute infections. While it can be used for a longer term to prevent certain infections from recurring, prolonged use must be managed carefully, as it can lead to the overgrowth of non-susceptible organisms.

Q: Is Farmacef a common medication, or is it only used for specific cases?

Farmacef is a widely available and frequently prescribed antibiotic. It is used to treat a variety of common bacterial infections, including those involving the skin, respiratory system, and urinary tract.

Q: Is Farmacef generally safe for people who have diabetes?

Official interaction data indicates that Farmacef can interact with the diabetes medication Metformin, potentially increasing its effects on blood sugar. It is also noted that Farmacef can cause a false-positive result on certain urine glucose (sugar) tests.

How should Farmacef be stored and disposed of?

Farmacef (Cefalexin) must be stored under specific conditions defined by regulatory labeling, which differ based on the form. Capsules and tablets must be maintained at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), and protected from moisture in the tightly closed original container.

Liquid Suspension Storage

Once the powder is mixed to create the liquid suspension, it must be stored in a refrigerator (2 C to 8 C) and must not be frozen. Any unused portion of the refrigerated suspension must be discarded after 14 days.

Child Safety and Disposal

All forms of this medication must be kept out of the sight and reach of children in a secure location. For disposal, unused or expired product should not be flushed down the toilet or poured down a drain. Instead, it should be mixed with an unappealing substance, sealed in a bag, and placed in the trash, following official guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Farmacef found in:

A-Z Index: